Benzinga | Jan 21, 2022 06:21AM EST

SVB Leerink Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $132

SVB Leerink analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $135 to $132.